EPIC-NL

European Prospective Investigation Into Cancer and Nutrition in the Netherlands (EPIC-NL)...

Description

EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed since the early 90's. Biological samples have been stored in liquid nitr...

General Design

Type
Cohort study
Cohort type
Population cohort
Data collection type
Prospective
Design
Longitudinal
Design description
At baseline, the prevalence of risk factors for chronic diseases was determined using self-administered questionnaires and a physical examination. Participants are followed up over time for changes in exposure and for the occurrence of cancer, diabetes, cardiovascular diseases, and other medical conditions.
Start/End data collection
1993 (ongoing)
Design paper
Cohort Profile: The EPIC-NL study

Population

Countries
Netherlands (the)
Regions
Limburg, Noord-Holland, Utrecht, Gelderland
Number of participants
40010
Population age groups
Adult (18+ years)
Inclusion criteria
Age group inclusion criterion

Organisations

Lead organisations
  • Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
  • UMC Utrecht (UMCU)
    Netherlands (the)

    Researcher

Contributors

Subpopulations

List of subpopulations for this resource...

No results for current selection

Collection events

List of collection events defined for this resource...

No results for current selection

Networks

Part of networks...

Publications

Access conditions

a data request is judged by the scientific steering committee...

Data access conditions
  • health or medical or biomedical research
  • disease specific research
Data use conditions
  • research specific restrictions
  • not for profit, non commercial use only
Data access fee
false
Release type
Other release type
Release description
at request
Prelinked
true
Linkage options
CBS (national bureau of statistics); IKNL-NKR (Cancer registration); GBA (municipal registry for current address and vital status)

Funding & Acknowledgements

Funding
The EPIC-NL study was funded by ‘Europe against Cancer’ Programme of the European Commission (SANCO); the Dutch Ministry of Public Health, Welfare and Sports (formerly Ministry of Welfare, Public Health and Culture); the Dutch Cancer Society; ZonMW the Netherlands Organisation for Health Research and Development; and World Cancer Research Fund (WCRF).
Acknowledgements
We thank GBA, Statistics Netherlands, Dutch Cancer Registry and the institute PHARMO for providing data on vital status, cause of death and occurrence of cancer and other chronic diseases.